DCF — ATRIUM HEALTH LINCOLN
Enterprise Value: $92.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$92.2M
Enterprise Value
$23.5M
PV of Cash Flows
$68.7M
PV of Terminal Value
$110.6M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $148.9M | $12.7M | 8.0% | $4.1M | $3.7M |
| Year 2 | $153.4M | $14.6M | 9.0% | $5.4M | $4.5M |
| Year 3 | $158.0M | $16.6M | 10.0% | $6.7M | $5.1M |
| Year 4 | $162.8M | $17.9M | 11.0% | $7.6M | $5.2M |
| Year 5 | $167.6M | $18.9M | 11.0% | $8.1M | $5.0M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $92.2M. Terminal value accounts for 75% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$144.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.07999999944675559
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5